Increased DKA at presentation among newly diagnosed type 1 diabetes patients with or without COVID-19: Data from a multi-site surveillance registry

Kara Beliard; Osagie Ebekozien; Carla Demeterco-Berggren; Guy Todd Alonso; Mary Pat Gallagher; Mark Clements; Robert Rapaport

doi:10.1111/1753-0407.13141

Increased DKA at presentation among newly diagnosed type 1 diabetes patients with or without COVID-19: Data from a multi-site surveillance registry

J Diabetes. 2021 Mar;13(3):270-272. doi: 10.1111/1753-0407.13141. Epub 2020 Dec 24.

Authors

Kara Beliard¹, Osagie Ebekozien², Carla Demeterco-Berggren³, Guy Todd Alonso⁴, Mary Pat Gallagher⁵, Mark Clements⁶, Robert Rapaport¹

Affiliations

¹ Mount Sinai Kravis Children's Hospital, Icahn School of Medicine, New York, New York, USA.
² T1D Exchange, Boston, Massachusetts, USA.
³ Rady Children's Hospital/University of California, San Diego, California, USA.
⁴ Barbara Davis Center, University of Colorado, Aurora, Colorado, USA.
⁵ Hassenfeld Children's Hospital at NYU Langone, New York, New York, USA.
⁶ Children Mercy Hospital, Kansas City, Missouri, USA.

PMID: 33283979
DOI: 10.1111/1753-0407.13141

Abstract

Highlights Our multicenter study reports a higher proportion of diabetic ketoacidosis presentation of over 60% in newly diagnosed patients with type 1 diabetes with or without confirmed coronavirus disease 2019 (COVID-19) at diagnosis. This finding is suggestive of delays in seeking care during the COVID-19 pandemic.

Keywords: COVID-19; diabetes ketoacidosis; new diagnosis; type 1 diabetes mellitus.

Publication types

Letter
Multicenter Study

MeSH terms

Adolescent
COVID-19 / complications*
COVID-19 / epidemiology*
Child
Child, Preschool
Diabetes Complications / epidemiology*
Diabetes Mellitus, Type 1 / complications*
Diabetes Mellitus, Type 1 / epidemiology*
Diabetic Ketoacidosis / epidemiology*
Female
Humans
Infant
Infant, Newborn
Male
Pandemics
Registries
Sex Factors
Socioeconomic Factors
United States / epidemiology
Young Adult